Advent Therapeutics is focused on providing therapies for micro-orphan applications.
Advent Therapeutics has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in July 2023.
Advent Therapeutics's investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, National Institutes of Health, Ben Franklin Technology Partners.
Advent Therapeutics is headquartered in Lumberville, United States.
Advent Therapeutics is focused on providing therapies for micro-orphan applications.
Advent Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Advent Therapeutics — Funding & Investors." VCBacked, July 18, 2023, https://www.vcbacked.co/company/advent-therapeutics. Accessed September 12, 2026.
VCBacked. (2023). Advent Therapeutics — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/advent-therapeutics
{{cite web |title=Advent Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/advent-therapeutics |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated